Open access · Peer reviewed · No APCs
CommentaryJournal of Pharmacology and PharmacotherapeuticsVol. 8 | Issue 3 | 2017 | pp. 134–6Open access
Why the Jan Aushadhi Scheme Has Lost Its Steam in India?
- 1*,
- 2,
- 3
- 1 People’s College of Medical Sciences and Research Centre, People’s University, Bhopal, Madhya Pradesh, India.
- 2 Centre for Scientific Research and Development, People’s University, Bhopal, Madhya Pradesh, India.
- 3 Dean, School of Pharmacy and Research, People’s University, Bhopal, Madhya Pradesh, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Vijay Thawani
People’s College of Medical Sciences and Research Centre, People’s University, Bhopal, Madhya Pradesh, India.
Email: vijaythawani@rediffmail.com
Copyright: © 2017 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2017
- Received:
- Mar 11, 2017
- Accepted:
- Jul 10, 2017
How to cite
Thawani, V., Mani, A., & Upmanyu, N. (2017). Why the Jan Aushadhi Scheme Has Lost Its Steam in India? Journal of Pharmacology and Pharmacotherapeutics, 8(3), 134–6. https://doi.org/10.4103/jpp.JPP_38_17
Abstract
The Jan Aushadhi Scheme (JAS) initiated by the Government of India is a powerful intervention against the unjustifiable pricing of medicines by private pharmaceutical industry, to make the generic medicines available at affordable prices. The marginalized populations of India are not able to afford many branded medicines; hence, there is an urgent need for making the cheaper generics available to Indians in the best interest of populations. It has been observed that lack of awareness in the public, distribution of free medicines by state governments, lack of support for JAS, poor supply chain, and doctors not prescribing generic medicines are the major constraints faced by the JAS leading to its poor success.
Keywords
Subject
Article metadata
| Title | Why the Jan Aushadhi Scheme Has Lost Its Steam in India? |
|---|---|
| Authors | Vijay Thawani; Abin Mani; Neeraj Upmanyu |
| Affiliations | People’s College of Medical Sciences and Research Centre, People’s University, Bhopal, Madhya Pradesh, India.; Centre for Scientific Research and Development, People’s University, Bhopal, Madhya Pradesh, India.; Dean, School of Pharmacy and Research, People’s University, Bhopal, Madhya Pradesh, India. |
| Corresponding author | vijaythawani@rediffmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 8, Issue 3 (2017) |
Also in this issue
- An Overview of the Extraarticular Involvement in Rheumatoid Arthritis and its Managementpp. 81–86
- Retrospection on the Role of Soluble Guanylate Cyclase in Parkinson’s Diseasepp. 87–91
- Biological Response Modifiers in Rheumatoid Arthritis: Systematic Review and Meta‑analysis of Safetypp. 92–105
- Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open‑label Studypp. 106–111
- Effect of Lorazepam in Reducing Psychological Distress and Anticipatory Nausea and Vomiting in Patients Undergoing Chemotherapypp. 112–5
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026